Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Multiple Sclerosis and Neuroimmunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1536853

Comparison of clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without cerebrospinal fluid oligoclonal bands: a cohort with 36-month follow-up

Provisionally accepted
  • 1 Department of Neurology, Huashan Hospital, Fudan University and Insitute of Neurology, Fudan University, National Center for Neurological Disorders, Shanghai, China
  • 2 Department of Neurology, NO. 905 Hospital of PLA Navy affiliated to Naval Medical University, Shanghai, China
  • 3 Human Phenome Institute, Fudan University, Shanghai, Shanghai Municipality, China

The final, formatted version of the article will be published soon.

    Purpose: To explore the significance of cerebrospinal fluid (CSF) oligoclonal bands (OCBs) in the clinical diagnosis and evaluation of neuromyelitis optica spectrum disorder (NMOSD).Methods: The demographic and clinical data of 143 AQP4-IgG positive NMOSD patients were collected and analyzed, including gender, age, clinical symptoms and signs, status of CSF OCBs, location and length of affected spinal cord vertebral segments, expanded disability status scale (EDSS) at first attack and 36-month follow-up, relapse times within 36 months, concomitant connective tissue disease (CTD) and other autoimmune antibodies (oAIA) status. Results: Fifteen patients (10.5%) were positive for OCBs (OCBs+). In contrast to those with negative OCBs (OCBs-), more OCBs+ cases had concomitant CTD (5/15 (33.3%) vs. 11/128 (8.6%), P=0.014) and oAIA (9/15 (60.0%) vs. 37/128 (28.9%), P=0.020). OCBs+ patients had higher CSF cell counts (15.0 (27.0) /mm3 vs. 5.0 (12.0) /mm3, P=0.008), higher IgG index (0.68 (0.23) vs. 0.52 (0.15), P<0.001), and more relapses within 36 months (2.0 (3.0) vs. 1.0 (2.0), P=0.039) than OCBs- patients. More OCBs+ patients had polynuclear cells predominance in CSF than OCBs- patients (P=0.032).There were no significant differences between the OCBs+ and the OCBs- groups in the distribution of lesion locations, length of affected spinal cord vertebral segments, CSF protein concentration and albumin quotient, EDSS score at the time of lumbar puncture and 36-month follow-up, as well as the onset episode, the relapse and cumulative clinical syndrome profiles (all P>0.05).Conclusions: For AQP4-IgG positive NMOSD patients, being positive for CSF OCBs is related with higher CSF cell counts and higher likelihood to have concomitant CTD and oAIA. OCBs+ is not uncommon in NMOSD, and may predict a more frequent relapses but not more serious illness.

    Keywords: Neuromyelitis optica spectrum disorder, Oligoclonal Bands, Clinical Characteristics, Laboratory characteristics, 36-month follow-up

    Received: 29 Nov 2024; Accepted: 24 Feb 2025.

    Copyright: © 2025 Yang, Liu, Wei, Hai, Wu, Wang, Deng, Wu, Chen and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Xiangjun Chen, Department of Neurology, Huashan Hospital, Fudan University and Insitute of Neurology, Fudan University, National Center for Neurological Disorders, Shanghai, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more